课题基金 / 基金详情

Exosomes as Endocrine Signaling Molecules in Cancer Cachexia

Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
外泌体作为癌症恶病质的内分泌信号分子
批准号:
10394305
负责人:
Daniel L. Marks
金额:
$43.1万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-10 至 2023-04-30

项目摘要

项目成果

Daniel L. Marks的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary: Illness behaviors and metabolic disturbances are common in pancreatic cancer patients, and may lead to wasting or cachexia. This devastating state of malnutrition is brought about by a synergistic combination of a decrease in appetite and an increase in metabolism of fat and lean body mass. The severity of cachexia in many illnesses is the primary determining factor in both quality of life, and in eventual mortality. Other illness- induced morbidities including lethargy also compromise the ability of patients to recover from life-saving or extending interventions, and diminish the motivational drive to aggressively battle the condition. Although cachexia in cancer patients was described more than two thousand years ago, the central mechanisms underlying this disorder are poorly understood. Furthermore, there is currently no effective pharmaceutical treatment. Our laboratory is dedicated to unraveling the basic neuroscience of cachexia. In this proposal, we will focus on understanding the scope and mechanism by which signals of pancreatic cancer development are received, amplified, and maintained by the hypothalamus. The significance of this proposal resides in its unique combination of our historical focus on neuroendocrinology and behavior, with new collaborations and efforts directed at understanding the role of extracellular vesicles in neuroinflammation. The long-term goal of our research is to gain mechanistic understanding of the acute illness response and how it is transitioned into chronic inflammation-associated cachexia in order to develop more effective therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
海外基金